Ertapenem Versus Meropenem for the Treatment of Extended Spectrum Beta-Lactamase-Producing Enterobacterales Bacteremia in Critically Ill Patients.
Saved in:
| Title: | Ertapenem Versus Meropenem for the Treatment of Extended Spectrum Beta-Lactamase-Producing Enterobacterales Bacteremia in Critically Ill Patients. |
|---|---|
| Authors: | VanDorf S; Department of Pharmacy, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA., Shah P; Department of Pharmacy, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA., Yost CN; Department of Pharmacy, Corewell Health William Beaumont University Hospital, Royal Oak, MI, USA. |
| Source: | The Annals of pharmacotherapy [Ann Pharmacother] 2024 Jul; Vol. 58 (7), pp. 690-697. Date of Electronic Publication: 2023 Oct 26. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: Sage Country of Publication: United States NLM ID: 9203131 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1542-6270 (Electronic) Linking ISSN: 10600280 NLM ISO Abbreviation: Ann Pharmacother Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
